-
Article
Increasing physical activity among older adults with gynecologic cancers: a qualitative study
The purpose of this study was to gain an understanding of older gynecologic cancer patients’ preferences and opinions related to physical activity during chemotherapy, including interventions to promote physic...
-
Reference Work Entry In depth
Ambulatory and Outpatient Care
-
Chapter
Cancer Drug Toxicity: Moving from Patient to Survivor
Millions of individuals worldwide are living with cancer and have remained disease-free for more than 5 years. These individuals are considered to be cancer survivors. The advent of new targeted therapies and ...
-
Chapter
Pharmacovigilance of Alternative Medications in the Cancer Setting
With the increase in utilization of alternative medications to manage cancer treatment-related side effects, pharmacovigilance of alternative drug therapies, specifically herbal supplements, has become of incr...
-
Chapter
Biosimilars: Are They Really Safe?
An increasing availability of biosimilars is an important step in the process of delivering optimal care while improving access for patients with cancer. Evolving regulatory mechanisms deal with biosimilars wi...
-
Chapter
Anatomy of Risk Evaluation and Mitigation Strategies (REMS)
This Chapter provides an introduction and overview of the U.S. FDA REMS program and applicable regulatory aspects. Topics covered include the 2015 Draft Guidance, organization structure and functions, a discus...
-
Chapter
Moonshot to Cancer Cure: Recruiting Policy to Break Down Silos
Funded by the 21st Century Cures Act, The Beau Biden Cancer Moonshot Initiative is broad, deep, integrative, and intended to expediently address cancer’s most vexing problems. Launched in 2015, it is an effort to...
-
Living Reference Work Entry In depth
Ambulatory and Outpatient Care
-
Chapter
Cancer Comorbidity: Implications for Drug Safety
Cancer is primarily a disease of aging. This chapter discusses relevant aspect of the physiology of aging, medication use and toxicity, comorbidities, and specific challenges in treating older adults with cancer.
-
Article
Improving Diversity in Cancer Research Trials: The Story of the Cancer Disparities Research Network
The participation of racial and ethnic minorities and underserved populations in clinical trials is a critical link between scientific innovation and improvements in health care delivery and health outcomes. H...
-
Article
Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report
Nephrogenic systemic fibrosis is a fibrosing disorder associated with exposure to gadolinium-based contrast agents in people with severely compromised renal function.
-
Article
Open AccessNavigating veterans with an abnormal prostate cancer screening test: a quasi-experimental study
Prostate cancer disproportionately affects low-income and minority men. This study evaluates the impact of a patient navigation intervention on timeliness of diagnostic resolution and treatment initiation amon...
-
Article
Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project
In 1998, a multidisciplinary team of investigators initiated the Research on Adverse Drug events And Reports (RADAR) project, a post-marketing surveillance effort that systematically investigates and dissemina...
-
Article
Open AccessDesign of a prostate cancer patient navigation intervention for a Veterans Affairs hospital
Patient navigation programs have been launched nationwide in an attempt to reduce racial/ethnic and socio-demographic disparities in cancer care, but few have evaluated outcomes in the prostate cancer setting....
-
Article
Adverse Drug Interactions
-
Article
Caveat patiens — ethical dilemmas in decision -making
More than 99,358 men, women and children are on organ transplant lists in the United States. Pressure on family members to donate organs can therefore be intense. The medical excuse was created to address this...
-
Article
Older Patients’ Perceptions of Medication Importance and Worth
Background: Cost-related medication non-adherence may be influenced by patients’ perceived importance of their medications.
-
Chapter
Does Reimbursement Affect Physicians’ Decision Making? Examples from the Use of Recombinent Erythropoietin
-
Article
Systematic Review of Piperacillin-Induced Neutropenia
Because penicillin agents are implicated in granulopoiesis inhibition, healthcare professionals frequently consider discontinuation of such therapy in patients with decreasing white blood cell counts. No syste...
-
Article
Granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in patients with small cell lung cancer
Recombinant granulocyte colony-stimulating factor (G-CSF) [filgrastim and lenograstim] and pegylated G-CSF (pegfilgrastim) have been shown to reduce the severity and duration of chemotherapy-associated febrile...
